Welcome to the InfoSci Platform
The Evolving Role of Pharmacoinformatics in Targeting Drug-Related Problems in Clinical Oncology Practice

The Evolving Role of Pharmacoinformatics in Targeting Drug-Related Problems in Clinical Oncology Practice

Kevin Yi-Lwern Yap
Copyright: © 2012 |Pages: 48
ISBN13: 9781466603097|ISBN10: 1466603097|EISBN13: 9781466603103
DOI: 10.4018/978-1-4666-0309-7.ch009
Cite Chapter Cite Chapter

MLA

Yap, Kevin Yi-Lwern. "The Evolving Role of Pharmacoinformatics in Targeting Drug-Related Problems in Clinical Oncology Practice." Pharmacoinformatics and Drug Discovery Technologies: Theories and Applications, edited by Tagelsir Mohamed Gasmelseid, IGI Global, 2012, pp. 130-177. https://doi.org/10.4018/978-1-4666-0309-7.ch009

APA

Yap, K. Y. (2012). The Evolving Role of Pharmacoinformatics in Targeting Drug-Related Problems in Clinical Oncology Practice. In T. Gasmelseid (Ed.), Pharmacoinformatics and Drug Discovery Technologies: Theories and Applications (pp. 130-177). IGI Global. https://doi.org/10.4018/978-1-4666-0309-7.ch009

Chicago

Yap, Kevin Yi-Lwern. "The Evolving Role of Pharmacoinformatics in Targeting Drug-Related Problems in Clinical Oncology Practice." In Pharmacoinformatics and Drug Discovery Technologies: Theories and Applications, edited by Tagelsir Mohamed Gasmelseid, 130-177. Hershey, PA: IGI Global, 2012. https://doi.org/10.4018/978-1-4666-0309-7.ch009

Export Reference

Mendeley
Favorite

Abstract

The rapid growth of the internet and the World Wide Web has led to the development of pharmacoinformatics technologies to assist oncology healthcare professionals in delivering optimum pharmaceutical care and health-related outcomes. The proliferation of online health information has also empowered patients with cancer with the knowledge to better participate in the management of their own condition. This chapter introduces the evolving roles of pharmacoinformatics in oncology and discusses some problems that have arisen due to these technologies. Various pharmacoinformatics channels for practitioners and patients are described together with drug interaction parameters that are clinically relevant to oncology clinicians. Additionally, this chapter addresses certain quality issues associated with online anticancer drug interactions and proposes several design principles for developers of pharmacoinformatics tools. Finally, readers will be given an insight as to how pharmacoinformatics can be harnessed for the future improvement of pharmaceutical care in patients with chronic diseases such as cancer.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.